# Efficacy and Safety of Atenas Association in the Treatment of Type II Diabetes Mellitus and Hypertension

> **NCT05144360** · PHASE3 · WITHDRAWN · sponsor: **EMS**

## Conditions studied

- Hypertension Associated
- Type II Diabetes Mellitus

## Interventions

- **DRUG:** Atenas
- **DRUG:** Atenas placebo

## Key facts

- **NCT ID:** NCT05144360
- **Lead sponsor:** EMS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-08
- **Primary completion:** 2024-07
- **Final completion:** 2024-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Strategy review
- **Last updated:** 2023-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05144360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05144360, "Efficacy and Safety of Atenas Association in the Treatment of Type II Diabetes Mellitus and Hypertension". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05144360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*